Detalhe da pesquisa
1.
Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs.
Blood
; 114(26): 5342-51, 2009 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19850739
2.
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536.
Haematologica
; 96(5): 672-80, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21242189
3.
Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis.
Langenbecks Arch Surg
; 394(2): 265-71, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18343942
4.
Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis.
Exp Hematol
; 36(11): 1461-70, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18723263
5.
Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha.
Exp Hematol
; 36(10): 1244-53, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18619723
6.
CLSI-Based Validation of Manufacturer-Derived Reference Intervals on the Cobas 8000 Platform.
Lab Med
; 48(2): e30-e35, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28398583
7.
Standardization of morbidity assessment in breast cancer surgery using the Clavien Dindo Classification.
Int J Surg
; 12(4): 334-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24486930
8.
Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.
Cancer Res
; 70(4): 1513-23, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20145140
9.
Lenalidomide therapy in systemic mastocytosis.
Leuk Res
; 33(3): e19-22, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18644623